Raymond Chung, MD
Massachusetts General Hospital
6
6
1
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+1 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Nezam Afdhal, MD
Beth Israel Deaconess Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Aijaz Ahmed, MD
Stanford University
Shared therapeutic areas:
Worked with same sponsors:
Norman Gitlin, MD
Atlanta Gastroenterology Associates
Shared therapeutic areas:
Worked with same sponsors:
Ira Jacobson, MD
New York Presbyterial-Weill Medical College of Cornell University
Shared therapeutic areas:
Worked with same sponsors:
Vinod Rustgi, MD
Metropolitan Research
Shared therapeutic areas:
Worked with same sponsors:
Ronald E Pruitt, MD
Nashville Medical Research Institute
Shared therapeutic areas:
Worked with same sponsors:
Arthur Berman, DO
Florida Center for Gastroenterology
Shared therapeutic areas:
Worked with same sponsors:
Joseph K Lim, MD
Yale University
Shared therapeutic areas:
Worked with same sponsors:
Bruce Bacon, MD
St. Louis University Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Mitchell L Shiffman, MD
McGuire Veteran's Administration Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
Safety and Efficacy of Atorvastatin v. Placebo on HCC Risk
Pegylated Interferon Lambda Treatment for COVID-19
HCV Post-Exposure Prophylaxis for Health Care Workers
DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant
Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidney Transplant
All 6 trials loaded